Exelixis, Inc. is a oncology-focused biopharmaceutical company that discovers, develops, and commercializes cancer treatments. The company's key marketed product is cabozantinib, sold under the brand names Cabometyx and Cometriq, approved for renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer. Exelixis also has a pipeline of additional oncology compounds in clinical development.
expected 2026-12-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-10 | 2026-01-02 | 0000939767-26-000021 | EDGAR | 46K words |
| 2025-02-11 | 2025-01-03 | 0000939767-25-000019 | EDGAR | 88K words |
| 2024-02-06 | 2023-12-29 | 0000939767-24-000028 | EDGAR | 88K words |
| 2023-02-07 | 2022-12-30 | 0000939767-23-000019 | EDGAR | 92K words |
| 2022-02-18 | 2021-12-31 | 0000939767-22-000026 | EDGAR | — |
| 2021-02-11 | 2021-01-01 | 0001628280-21-001852 | EDGAR | — |
| 2020-02-25 | 2020-01-03 | 0000939767-20-000035 | EDGAR | — |
| 2019-02-22 | 2018-12-28 | 0000939767-19-000042 | EDGAR | — |
| 2018-02-26 | 2017-12-29 | 0000939767-18-000023 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-07-03 | 0000939767-26-000098 | EDGAR | 24K words |
| 2025-11-04 | 2025-10-03 | 0000939767-25-000128 | EDGAR | 26K words |
| 2025-07-28 | 2025-07-04 | 0000939767-25-000113 | EDGAR | 24K words |
| 2025-05-13 | 2025-04-04 | 0000939767-25-000075 | EDGAR | 25K words |
| 2024-10-29 | 2024-09-27 | 0000939767-24-000150 | EDGAR | 30K words |
| 2024-08-06 | 2024-06-28 | 0000939767-24-000119 | EDGAR | 27K words |
| 2024-04-30 | 2024-03-29 | 0000939767-24-000058 | EDGAR | 25K words |
| 2023-11-01 | 2023-09-29 | 0000939767-23-000114 | EDGAR | 31K words |
| 2023-08-01 | 2023-06-30 | 0000939767-23-000079 | EDGAR | 33K words |
| 2023-05-09 | 2023-03-31 | 0000939767-23-000048 | EDGAR | 29K words |
| 2022-11-01 | 2022-09-30 | 0000939767-22-000110 | EDGAR | — |
| 2022-08-09 | 2022-07-01 | 0000939767-22-000097 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-11 | 0000939767-26-000108 | EDGAR | 0K words |
| 2026-08-31 | 0000939767-26-000104 | EDGAR | 1K words |
| 2026-08-05 | 0000939767-26-000096 | EDGAR | 5K words |
| 2026-02-10 | 0000939767-26-000019 | EDGAR | 5K words |
| 2026-01-12 | 0000939767-26-000003 | EDGAR | 4K words |
| 2025-11-07 | 0000939767-25-000133 | EDGAR | 1K words |
| 2025-11-04 | 0000939767-25-000127 | EDGAR | 5K words |
| 2025-08-29 | 0000939767-25-000115 | EDGAR | 1K words |
| 2025-07-28 | 0000939767-25-000111 | EDGAR | 5K words |
| 2025-06-02 | 0000939767-25-000097 | EDGAR | 1K words |
143 total filings indexed. 112 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000939767 |
| Ticker | EXEL |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.exelixis.com |
| Listed | 2000-04-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/EXEL (~200 tokens, structured JSON with cryptographic provenance)